Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 1
1927 1
1951 1
1975 1
1978 1
1979 1
1980 2
1983 1
1998 1
2001 1
2004 1
2005 1
2006 2
2008 1
2012 1
2016 1
2018 1
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Review article: acute severe ulcerative colitis - evidence-based consensus statements.
Chen JH, Andrews JM, Kariyawasam V, Moran N, Gounder P, Collins G, Walsh AJ, Connor S, Lee TW, Koh CE, Chang J, Paramsothy S, Tattersall S, Lemberg DA, Radford-Smith G, Lawrance IC, McLachlan A, Moore GT, Corte C, Katelaris P, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Chen JH, et al. Among authors: tattersall s. Aliment Pharmacol Ther. 2016 Jul;44(2):127-44. doi: 10.1111/apt.13670. Epub 2016 May 26. Aliment Pharmacol Ther. 2016. PMID: 27226344 Free article. Review.
When to use biological agents in inflammatory bowel disease.
Corte C, Saxena P, Tattersall S, Selinger C, Leong RW. Corte C, et al. Among authors: tattersall s. J Gastroenterol Hepatol. 2012 Jul;27(7):1141-9. doi: 10.1111/j.1440-1746.2011.07056.x. J Gastroenterol Hepatol. 2012. PMID: 22188169
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.
Lenti MV, Levison S, Eliadou E, Willert R, Kemp K, Carter A, Stansfield C, Assadsangabi A, Singh S, Crooks B, Tattersall S, Fairhurst F, Kenneth C, Subramanian S, Probert C, Storey D, Gregg B, Smith P, Liu E, Limdi JK, Johnston A, Hamlin PJ, Selinger CP. Lenti MV, et al. Among authors: tattersall s. Dig Liver Dis. 2018 Dec;50(12):1299-1304. doi: 10.1016/j.dld.2018.07.007. Epub 2018 Jul 18. Dig Liver Dis. 2018. PMID: 30077465 Free article.
Systematic response to talc pleurodesis.
Gill AJ, Mathur MN, Tattersall SF. Gill AJ, et al. Among authors: tattersall sf. Am J Respir Crit Care Med. 2004 May 1;169(9):1074; author reply 1074-5. doi: 10.1164/ajrccm.169.9.958. Am J Respir Crit Care Med. 2004. PMID: 15107308 No abstract available.
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.
Lenti MV, Dolby V, Clark T, Hall V, Tattersall S, Fairhurst F, Kenneth C, Walker R, Kemp K, Borg-Bartolo S, Limdi JK, Taylor J, Townsend T, Subramanian S, Storey D, Assadsangabi A, Stansfield C, Smith P, Byrne D, De Silvestri A, Selinger CP. Lenti MV, et al. Among authors: tattersall s. Aliment Pharmacol Ther. 2022 Apr;55(7):856-866. doi: 10.1111/apt.16742. Epub 2021 Dec 22. Aliment Pharmacol Ther. 2022. PMID: 34935160
Hospitalised patients' views on doctors and white coats.
Gooden BR, Smith MJ, Tattersall SJ, Stockler MR. Gooden BR, et al. Among authors: tattersall sj. Med J Aust. 2001 Aug 20;175(4):219-22. doi: 10.5694/j.1326-5377.2001.tb143103.x. Med J Aust. 2001. PMID: 11587285
22 results